These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9916140)

  • 1. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
    Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
    J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses.
    Howard LM; Dal Canto MC; Miller SD
    J Neuroimmunol; 2002 Aug; 129(1-2):58-65. PubMed ID: 12161021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.
    Howard LM; Ostrovidov S; Smith CE; Dal Canto MC; Miller SD
    J Clin Invest; 2002 Jan; 109(2):233-41. PubMed ID: 11805135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
    Mohindru M; Kang B; Kim BS
    J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
    Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
    J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodies.
    Nagelkerken L; Haspels I; van Rijs W; Blauw B; Ferrant JL; Hess DM; Garber EA; Taylor FR; Burkly LC
    J Immunol; 2004 Jul; 173(2):993-9. PubMed ID: 15240687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.
    Laman JD; Maassen CB; Schellekens MM; Visser L; Kap M; de Jong E; van Puijenbroek M; van Stipdonk MJ; van Meurs M; Schwärzler C; Günthert U
    Mult Scler; 1998 Jun; 4(3):147-53. PubMed ID: 9762665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE; Vanderlugt CL; Nickerson-Nutter C; Cornebise M; Scott DM; Perper SJ; Whalley ET; Miller SD
    Blood; 2003 Dec; 102(13):4464-71. PubMed ID: 12933585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.
    Podojil JR; Kohm AP; Miller SD
    J Immunol; 2006 Sep; 177(5):2948-58. PubMed ID: 16920930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated Th1 autoreactive effector cells can induce experimental autoimmune encephalomyelitis in the absence of IL-12 and CD40/CD40L interactions.
    Mendel I; Shevach EM
    J Neuroimmunol; 2002 Jan; 122(1-2):65-73. PubMed ID: 11777544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL; Dal Canto MC; Bluestone JA; Miller SD
    J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
    Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
    Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
    Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
    J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.
    Marín N; Eixarch H; Mansilla MJ; Rodríguez-Martín E; Mecha M; Guaza C; Álvarez-Cermeño JC; Montalban X; Villar LM; Espejo C
    Clin Exp Immunol; 2014 Feb; 175(2):202-7. PubMed ID: 24188195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.